Bruce Press joins Inflexa as Strategic Business Development Advisor
Three decades across the science, the technology, and the business of pharma innovation
Bruce Press
Strategic Business Development Advisor
We're glad to share that Bruce Press is joining Inflexa as our Strategic Business Development Advisor.
Bruce has spent more than 30 years building and commercializing enterprise life science platforms across bioinformatics, advanced computing, and AI for drug discovery. He's one of those rare people who's fluent in all three languages that matter here — the science, the technology, and the business of getting real innovation adopted inside big pharma.
The science
Decades close to bioinformatics and the questions translational teams actually need answered.
The technology
Advanced computing and AI for drug discovery, built and shipped as enterprise platforms.
The business
Getting real innovation adopted inside big pharma — the part that decides whether good work matters.
That's exactly the work ahead of us. We're building AI infrastructure for scientific analysis in biopharma: tools that go deep, show their work, and give teams something they can actually act on. Bruce knows this terrain well, and his experience will matter a great deal as we grow our partnerships across pharma and biotech and keep building Inflexa into a platform serious translational teams can rely on.
Glad to have you on board, Bruce.
Building something in this space?
If you're working on translational science across pharma or biotech, we'd love to talk.